Literature DB >> 9756151

Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1.

K Eder1, S J Kish, M Kirchgessner, B M Ross.   

Abstract

Previous studies of patients with spinocerebellar atrophy type 1 (SCA-1) and Friedreich's ataxia (FA) have suggested the occurrence of membrane disturbances in both disorders. We measured concentrations of phosphatidylcholine (PC), diacyl and plasmalogen phosphatidylethanolamine (PE), and phosphatidylserine (PS), along with their fatty acid profiles, in the brains of eight patients with Friedreich's ataxia (FA) and nine patients with dominantly inherited spinocerebellar atrophy type 1 (SCA-1). Compared with the controls, levels of all phospholipid types (PE, PS, and PC) were reduced in the cerebellar but not occipital cortex of SCA-1 patients. In contrast, in the FA group, levels of PS and PE, but not PC, were reduced in both cerebellar and occipital cortices. The fatty acid composition of individual brain phospholipids was altered in both FA and SCA-1 patients, most markedly in the plasmalogen PE and PS classes of cerebellar phospholipids. Given the neuropathologic characteristics of each disorder, it is likely that altered fatty acid composition and phospholipid levels in SCA-1 cerebellar cortex occur as a consequence of pronounced cerebellar degeneration. In contrast, reduced phospholipid levels in FA cerebellar and occipital cortex, areas characterized by, at most, minimal neuronal loss in FA, may represent a widespread alteration in cellular phospholipid metabolism occurring in response to the specific gene defect in the disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756151     DOI: 10.1002/mds.870130510

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

Review 1.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

2.  A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich's ataxia.

Authors:  Marcondes C França; Anelyssa D'Abreu; Clarissa L Yasuda; Luciana Cardoso Bonadia; Marilza Santos da Silva; Anamarli Nucci; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

3.  Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1.

Authors:  Uzay E Emir; Howard Brent Clark; Manda L Vollmers; Lynn E Eberly; Gülin Öz
Journal:  J Neurochem       Date:  2013-09-17       Impact factor: 5.372

4.  Altered lipid metabolism in a Drosophila model of Friedreich's ataxia.

Authors:  Juan A Navarro; Elisabeth Ohmann; Diego Sanchez; José A Botella; Gerhard Liebisch; María D Moltó; María D Ganfornina; Gerd Schmitz; Stephan Schneuwly
Journal:  Hum Mol Genet       Date:  2010-05-10       Impact factor: 6.150

Review 5.  Antioxidant Therapies and Oxidative Stress in Friedreich´s Ataxia: The Right Path or Just a Diversion?

Authors:  Laura R Rodríguez; Tamara Lapeña; Pablo Calap-Quintana; María Dolores Moltó; Pilar Gonzalez-Cabo; Juan Antonio Navarro Langa
Journal:  Antioxidants (Basel)       Date:  2020-07-24

6.  Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.

Authors:  Marta Manes; Antonella Alberici; Eleonora Di Gregorio; Loredana Boccone; Enrico Premi; Nico Mitro; Maria Pia Pasolini; Claudia Pani; Barbara Paghera; Daniela Perani; Laura Orsi; Chiara Costanzi; Marta Ferrero; Adele Zoppo; Filippo Tempia; Donatella Caruso; Mario Grassi; Alessandro Padovani; Alfredo Brusco; Barbara Borroni
Journal:  Ann Neurol       Date:  2017-10-22       Impact factor: 11.274

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.